Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from Lung Kee (Bermuda) Holdings Limited ( (HK:0255) ) is now available.
Lung Kee Group Holdings Limited has scheduled a board meeting for 20 March 2026 in Hong Kong to review and approve the audited final results of the company and its subsidiaries for the financial year ended 31 December 2025. The board will also consider a recommendation on the payment of a final dividend, a decision that could affect shareholder returns and signal management’s confidence in the group’s recent operating performance.
The announcement confirms the meeting’s timing and venue and lists the current composition of the board, including both executive and independent non-executive directors. Investors and other stakeholders will look to the forthcoming results and dividend proposal for insight into the company’s financial health and capital allocation priorities after the 2025 financial year.
The most recent analyst rating on (HK:0255) stock is a Hold with a HK$1.50 price target. To see the full list of analyst forecasts on Lung Kee (Bermuda) Holdings Limited stock, see the HK:0255 Stock Forecast page.
More about Lung Kee (Bermuda) Holdings Limited
Lung Kee Group Holdings Limited, incorporated in Bermuda and listed in Hong Kong, operates in the industrial manufacturing sector, historically known for mold base and related engineering products. The company serves manufacturers in Greater China and international markets, providing core components and services for tooling and production processes.
Average Trading Volume: 81,669
Technical Sentiment Signal: Hold
Current Market Cap: HK$912.8M
Learn more about 0255 stock on TipRanks’ Stock Analysis page.